Vigencia de la acetazolamida en la terapéutica diurética actual: aplicaciones en el edema refractario y la hiperpotasemia relacionada al bloqueo aldosterónico
Actuality of the use of acetazolamide as a diuretic: usefulness in refractory edema and in aldosteroneantagonist- related hyperkalemia
Leído
56226
Vecesse ha leído el artículo
5438
Total PDF
50788
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 164 | 6 | 170 |
| 2025 5 | 722 | 61 | 783 |
| 2025 4 | 723 | 65 | 788 |
| 2025 3 | 853 | 106 | 959 |
| 2025 2 | 773 | 72 | 845 |
| 2025 1 | 721 | 82 | 803 |
| 2024 12 | 1082 | 54 | 1136 |
| 2024 11 | 608 | 84 | 692 |
| 2024 10 | 643 | 80 | 723 |
| 2024 9 | 727 | 74 | 801 |
| 2024 8 | 776 | 116 | 892 |
| 2024 7 | 713 | 77 | 790 |
| 2024 6 | 704 | 78 | 782 |
| 2024 5 | 835 | 81 | 916 |
| 2024 4 | 921 | 73 | 994 |
| 2024 3 | 852 | 51 | 903 |
| 2024 2 | 740 | 78 | 818 |
| 2024 1 | 700 | 60 | 760 |
| 2023 12 | 590 | 59 | 649 |
| 2023 11 | 732 | 83 | 815 |
| 2023 10 | 805 | 71 | 876 |
| 2023 9 | 764 | 62 | 826 |
| 2023 8 | 672 | 56 | 728 |
| 2023 7 | 605 | 65 | 670 |
| 2023 6 | 653 | 77 | 730 |
| 2023 5 | 699 | 95 | 794 |
| 2023 4 | 522 | 71 | 593 |
| 2023 3 | 427 | 46 | 473 |
| 2023 2 | 366 | 58 | 424 |
| 2022 1 | 322 | 61 | 383 |
| 2022 12 | 347 | 67 | 414 |
| 2022 11 | 381 | 52 | 433 |
| 2022 10 | 353 | 92 | 445 |
| 2022 9 | 372 | 55 | 427 |
| 2022 8 | 300 | 79 | 379 |
| 2022 7 | 259 | 66 | 325 |
| 2022 6 | 203 | 75 | 278 |
| 2022 5 | 264 | 76 | 340 |
| 2022 4 | 223 | 75 | 298 |
| 2022 3 | 220 | 77 | 297 |
| 2022 2 | 236 | 76 | 312 |
| 2021 1 | 208 | 45 | 253 |
| 2021 12 | 204 | 50 | 254 |
| 2021 11 | 293 | 64 | 357 |
| 2021 10 | 285 | 82 | 367 |
| 2021 9 | 237 | 62 | 299 |
| 2021 8 | 506 | 46 | 552 |
| 2021 7 | 271 | 52 | 323 |
| 2021 6 | 241 | 42 | 283 |
| 2021 5 | 274 | 69 | 343 |
| 2021 4 | 621 | 86 | 707 |
| 2021 3 | 399 | 55 | 454 |
| 2021 2 | 387 | 40 | 427 |
| 2020 1 | 322 | 25 | 347 |
| 2020 12 | 318 | 38 | 356 |
| 2020 11 | 356 | 25 | 381 |
| 2020 10 | 308 | 49 | 357 |
| 2020 9 | 349 | 31 | 380 |
| 2020 8 | 270 | 26 | 296 |
| 2020 7 | 359 | 46 | 405 |
| 2020 6 | 775 | 43 | 818 |
| 2020 5 | 380 | 42 | 422 |
| 2020 4 | 585 | 45 | 630 |
| 2020 3 | 512 | 29 | 541 |
| 2020 2 | 515 | 45 | 560 |
| 2020 1 | 518 | 33 | 551 |
| 2019 12 | 445 | 28 | 473 |
| 2019 11 | 486 | 38 | 524 |
| 2019 10 | 499 | 39 | 538 |
| 2019 9 | 636 | 64 | 700 |
| 2019 8 | 527 | 29 | 556 |
| 2019 7 | 492 | 51 | 543 |
| 2019 6 | 322 | 29 | 351 |
| 2019 5 | 422 | 27 | 449 |
| 2019 4 | 419 | 51 | 470 |
| 2019 3 | 297 | 51 | 348 |
| 2019 2 | 180 | 27 | 207 |
| 2019 1 | 212 | 36 | 248 |
| 2018 12 | 458 | 47 | 505 |
| 2018 11 | 351 | 43 | 394 |
| 2018 10 | 327 | 49 | 376 |
| 2018 9 | 249 | 38 | 287 |
| 2018 8 | 156 | 28 | 184 |
| 2018 7 | 131 | 26 | 157 |
| 2018 6 | 167 | 23 | 190 |
| 2018 5 | 182 | 17 | 199 |
| 2018 4 | 170 | 19 | 189 |
| 2018 3 | 136 | 14 | 150 |
| 2018 2 | 124 | 8 | 132 |
| 2018 1 | 80 | 14 | 94 |
| 2017 12 | 108 | 13 | 121 |
| 2017 11 | 119 | 25 | 144 |
| 2017 10 | 137 | 24 | 161 |
| 2017 9 | 117 | 19 | 136 |
| 2017 8 | 128 | 27 | 155 |
| 2017 7 | 79 | 20 | 99 |
| 2017 6 | 101 | 32 | 133 |
| 2017 5 | 134 | 50 | 184 |
| 2017 4 | 84 | 19 | 103 |
| 2017 3 | 98 | 50 | 148 |
| 2017 2 | 196 | 41 | 237 |
| 2016 1 | 86 | 31 | 117 |
| 2016 12 | 102 | 24 | 126 |
| 2016 11 | 131 | 43 | 174 |
| 2016 10 | 203 | 41 | 244 |
| 2016 9 | 376 | 49 | 425 |
| 2016 8 | 377 | 37 | 414 |
| 2016 7 | 301 | 35 | 336 |
| 2016 6 | 224 | 0 | 224 |
| 2016 5 | 236 | 0 | 236 |
| 2016 4 | 166 | 0 | 166 |
| 2016 3 | 158 | 0 | 158 |
| 2016 2 | 180 | 0 | 180 |
| 2015 1 | 187 | 0 | 187 |
| 2015 12 | 170 | 0 | 170 |
| 2015 11 | 143 | 0 | 143 |
| 2015 10 | 136 | 0 | 136 |
| 2015 9 | 127 | 0 | 127 |
| 2015 8 | 144 | 0 | 144 |
| 2015 7 | 116 | 0 | 116 |
| 2015 6 | 107 | 0 | 107 |
| 2015 5 | 121 | 0 | 121 |
| 2015 4 | 7 | 0 | 7 |
| 2015 2 | 5156 | 0 | 5156 |
Mostrar todo
